Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
NCT00824070 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 105
Last updated 2011-12-13
Summary
This study is being conducted to assess the concentration of besifloxacin, moxifloxacin, or gatifloxacin in aqueous humor samples collected following topical instillation of the associated formulation in subjects undergoing cataract surgery.
Conditions
- Cataract Extraction
Interventions
- DRUG
-
Besifloxacin hydrochloride
Instill besifloxacin study medication in the study eye prior to making an incision for cataract extraction surgery.
- DRUG
-
moxifloxacin hydrochloride
Instill moxifloxacin study medication in the study eye prior to making an incision for cataract extraction surgery.
- DRUG
-
gatifloxacin
Instill gatifloxacin study medication in the study eye prior to making an incision for cataract extraction surgery.
Sponsors & Collaborators
-
Bausch & Lomb Incorporated
lead INDUSTRY
Principal Investigators
-
Eric Donnefeld · Ophthalmic Consultants of Long Island
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2009-07-31
- Completion
- 2009-08-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.
NCT02770729 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Topical Besifloxacin on Ocular Surface Bacterial Microbiota Prior to Cataract Surgery
NCT04542759 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
NCT00703781 ·Status: COMPLETED ·Phase: PHASE3
-
PRO-232 in Patients Subjected to Cataract Surgery
NCT07305987 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
NCT00704418 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery
NCT00870103 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.
NCT01928693 ·Status: TERMINATED ·Phase: PHASE2
-
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
NCT01023724 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT01367249 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Variables in Cataract Surgery
NCT00407017 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery
NCT03244072 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers
NCT05990712 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Study of Tobradex AF
NCT00473070 ·Status: COMPLETED ·Phase: PHASE3
-
A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery
NCT03634852 ·Status: COMPLETED ·Phase: PHASE4
-
Eye Surface Properties After Using Dexamethasone Drops With and Without Preservatives in Patients After Cataract Surgery
NCT05753787 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates
NCT00579020 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Postoperative Inflammation in Cataract Surgery
NCT00331084 ·Status: COMPLETED ·Phase: NA
-
Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery
NCT06785090 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery
NCT04739709 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction
NCT02973880 ·Status: COMPLETED ·Phase: PHASE3
-
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
NCT00630019 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)
NCT00414011 ·Status: COMPLETED ·Phase: NA
-
Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery
NCT00335231 ·Status: WITHDRAWN ·Phase: NA
-
VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract Surgery
NCT01515826 ·Status: WITHDRAWN ·Phase: PHASE3
-
Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery
NCT01387464 ·Status: COMPLETED ·Phase: PHASE2